Aya Fukuma Ozaki

Picture of Aya Fukuma Ozaki
Assistant Professor of Clinical Pharmacy
School of Pharmacy & Pharmaceutical Sciences
B.S., School of Pharmaceutical Sciences, Toho University, Japan, Pharmacology
Pharm.D., College of Pharmacy, Western University of Health Sciences
Phone: (949)824-3942
Email: afozaki@uci.edu
University of California, Irvine
Berk Hall, 106D
Mail Code: 3958
Irvine, CA 92697
Research Interests
Cardiovascular diseases, medication utilization, pharmacogenomics, health disparities, evidence-based medicine
Awards and Honors
2022 Best Poster Presentation Award
Asian Conference on Clinical Pharmacy

2020 Early Career Investigator Travel Grant
American Heart Association, Quality of Care and Outcomes Research Conference

2015 Summer Student Research Fellowship
Western University of Health Sciences
Publications
12 Urano K, Hatano N, Ozeki K, Komoda M, Kawahara M, Ozaki AF. How to promote practical EBM education - The learning cycle in university and clinical practice. Japan Society of Pharmaceutical Education. (Accepted) Description: I contributed to designing the study, drafting and critical revision of the manuscript.
11 Ozaki AF, Jackevicius CA, Chong A, Sud M, Fang J, Austin PC, Ko DT. Hospital-level variation in ticagrelor use in patients with acute coronary syndrome. J Am Heart Assoc. 2022;11(13):e024835. Description: I led the research team, designed the study, drafted and finalized the manuscript.
10 Ozaki AF, Cadiz C, Hurley-Kim K, Wisseh C, Knox E, Lee JY, Wong A, Patel SG, Chan A. worldwide characteristics and trends of pharmacist interventions contributed to minimize health disparities. J Am Coll Clin Pharm. 2022;5(8):853-64 Description: As a primary and corresponding author, I led the team to develop the study, collect and analyze data, and write the manuscript.
9 Hurley-Kim K, Unonu J, Wisseh C, Cadiz C, Knox E, Ozaki AF, Chan A. Health disparities in pharmacy practice within the community: Let's brainstorm for solutions. Front Public Health. 2022;10:847696. Description: I contributed to designing the study, drafting and critical revision of the manuscript.
8 Ozaki AF, Krumholz HM, Mody FV, et al. Prior authorization, copayments, and utilization of sacubitril/valsartan in medicare and commercial plans in patients with heart failure with reduced ejection fraction [published online ahead of print, 2021 Sep 1]. Circ Cardiovasc Qual Outcomes 2021;CIRCOUTCOMES120007665. Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
7 Ozaki AF, Krumholz HM, Mody FV, Jackevicius CA. National trends in the use of sacubitril/valsartan. J Card Fail 2021;27:839-47. Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
6 Hamaguchi S, Kariya M, Ozaki AF, Namekata I, Tanaka H. Contribution of ATP-mediated positive feedback to sympathetic nerve-induced positive inotropy in guinea pig ventricular myocardium. Biol Pharm Bull 2021;44:458-60. Description: I contributed to designing the study and critical revision of the manuscript
5 Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020;13:e005969. doi:10.1161/CIRCOUTCOMES.119.005969 Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
4 Jackevicius CA, Krumholz HM, Chong A, Koh M, Ozaki AF, Austin PC, Udell JA, Ko DT. Population impact of generic valsartan recall. Circulation. 2020;141:411-3. doi:10.1161/CIRCULATIONAHA.119.044494 Description: I contributed to designing the study, and critical revision of the manuscript.
3 Ny P, Ozaki AF, Pallares J, Nieberg P, Wong-Beringer A. Antimicrobial stewardship opportunities in patients with bacteremia not identified by BioFire FilmArrary. J Clin Microbiol. 2019 Apr;57(5). Pii: e01941-18. doi: 10.1128/JCM.01941-18 Description: I contributed to designing the study and analyzing data.
2 Ozaki AF, Jackevicius CA. Evidence-based practice review of the ASCEND Trial. J Contemp Pharm Practice. 2019;66:48-52 Description: I designed the study, analyzed, drafted and revised the manuscript.
1 Ozaki AF, Nakagawa S, Jackevicius CA. Cross-cultural comparison of pharmacy students’ attitudes, knowledge, practice, and barriers regarding evidence-based medicine. Am J Pharm Educ. 2017; Published online ahead of print Dec 12, 2017. doi/pdf/10.5688/ajpe6710 Description: I led the research team, designed the study, analyzed, drafted and finalized the manuscript.
Other Experience
Fellow in Cardiovascular Outcomes Research
Western University of Health Sciences, Practice Site: Veterans Affair Greater Los Angeles 2018—2021
Last updated
03/16/2023